misleading marketing

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Kirby Mcinerney Llp

ImmunityBio Faces Securities Fraud Lawsuit Over Anktivas Marketing Claims

Kirby McInerney LLP filed securities fraud lawsuit against ImmunityBio over allegedly misleading Anktivas marketing. FDA warning letter triggered 21.2% stock decline.
KDIBRXSMCIsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Robbins Geller Rudman & Dowd Llp

ImmunityBio Faces Class Action Lawsuit Over Anktiva Cancer Claims

Class action lawsuit filed against ImmunityBio for allegedly making false statements about cancer treatment Anktiva. FDA issued warning letter; stock fell 21% after disclosure.
IBRXsecurities fraudclass action lawsuit